Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kitsHead-to-head comparison ...

Blood test analyzes DNA fragments to detect and pinpoint early liver transplant complications, offering safer, faster, and ...

Grail is preparing to file for FDA approval of its Galleri test for detecting multiple cancers from a single blood test after ...

Key Laboratory of Genomics and Precision Medicine, and China National Center for Bioinformation, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China University of Chinese ...

Cancers that shed cfDNA in a limited amount at early stages, cancers that do not shed, or cancers that grow rapidly may be diagnosed at late stage by usual care in the interval between MCED tests. If ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally ...

Studying the chemical signatures of DNA fragments in the blood could help scientists pinpoint the cause of organ damage ...

However, the 5hmC modification status in circulating cell-free DNA (cfDNA) of patients with SLE remains largely unexplored. We investigated the distribution of 5hmC in cfDNA of patients with SLE and ...

Salivary cell-free DNA methylation analysis for oncological monitoring of surgical resection of oral squamous cell carcinoma Zuzana Saidak 1,2,3* Marie Milly 2 Christophe Louandre 1,2 Emilien Colin ...

According to a new study by Renub Research, the United States Non-Invasive Prenatal Testing Market is set to experience ...